# The Effectiveness and Safety of Topiramate on Prevention of Chronic Migraine

> **NCT00216606** · PHASE3 · COMPLETED · sponsor: **Janssen Pharmaceutica N.V., Belgium** · enrollment: 59 (actual)

## Conditions studied

- Migraine

## Interventions

- **DRUG:** topiramate

## Key facts

- **NCT ID:** NCT00216606
- **Lead sponsor:** Janssen Pharmaceutica N.V., Belgium
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-12
- **Primary completion:** —
- **Final completion:** 2005-07
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2011-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00216606

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00216606, "The Effectiveness and Safety of Topiramate on Prevention of Chronic Migraine". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00216606. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*